Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Baggio

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
ACS Chemical Biology|August 16, 2018
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in CellLuca Gambini, Ahmed F Salem, Parima Udompholkul, et al.
ACS Chemical Biology|December 28, 2016
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer AgentsElisa Barile, Guya D Marconi, Surya K De, et al.
Journal of Medicinal Chemistry|February 23, 2018
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug ConjugateAhmed F Salem, Si Wang, Sandrine Billet, et al.
Iscience|August 29, 2022
EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytesCassandra Dennys, Carlo Baggio, Rochelle Rodrigo, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ACS Chemical Biology|August 16, 2018
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in CellLuca Gambini, Ahmed F Salem, Parima Udompholkul, et al.
ACS Chemical Biology|December 28, 2016
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer AgentsElisa Barile, Guya D Marconi, Surya K De, et al.
Journal of Medicinal Chemistry|February 23, 2018
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug ConjugateAhmed F Salem, Si Wang, Sandrine Billet, et al.
Iscience|August 29, 2022
EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytesCassandra Dennys, Carlo Baggio, Rochelle Rodrigo, et al.
Pageof 3